Operation, hormone therapy and recovery of the patients with severe forms of adenomyosis

References

• Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update. Fertil Steril 2012;98:572–9.
   PubMed Web of Science ®Google Scholar
• Huang X, Huang Q, Chen S, et al. Efficacy of laparoscopic adenomyomectomy using double-flap method for diffuse uterine adenomyosis. BMC Womens Health 2015;15:24.
   PubMed Web of Science ®Google Scholar
• Pelage L, Fenomanana S, Brun JL, et al. Treatment of adenomyosis (excluding pregnancy project). Gynecol Obstet Fertil 2015;43:404–11.
   PubMedGoogle Scholar
• Harada T, Khine YM, Kaponis A, et al. The impact of adenomyosis on women’s fertility. Obstet Gynecol Surv 2016;71:557–68.
   PubMed Web of Science ®Google Scholar
• Matalliotakis IM, Katsikis IK, Panidis DK. Adenomyosis: what is the impact on fertility? Curr Opin Obstet Gynecol 2005;17:261–4.
   PubMed Web of Science ®Google Scholar
• Leyendecker G, Kunz G, Kissler S, Wildt L. Adenomyosis and reproduction. Best Pract Res Clin Obstet Gynaecol 2006;20:523–46.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Consonni D, Barbara G, et al. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis. Reprod Biomed Online 2014;28:704–13.
   PubMed Web of Science ®Google Scholar
• Koch J, Rowan K, Rombauts L, et al. Endometriosis and infertility – a consensus statement from ACCEPT. Aust N Z J Obstet Gynaecol 2012;52:513–22.
   PubMed Web of Science ®Google Scholar
• Pontis A, D’Alterio MN, Pirarba S, et al. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol 2016;32:696–700.
   PubMed Web of Science ®Google Scholar
• Koo YJ, Im KS, Kwon YS. Conservative surgical treatment combined with GnRH agonist in symptomatic uterine adenomyosis. Pak J Med Sci 2011;27:365–70.
   Web of Science ®Google Scholar
• Nishida M, Takano K, Arai Y, et al. Conservative surgical management for diffuse uterine adenomyosis. Fertil Steril 2010;94:715–19.
   PubMed Web of Science ®Google Scholar
• Ozaki T, Takahashi K, Okada M, et al. Live birth after conservative surgery for severe adenomyosis following magnetic resonance imaging and gonadotropin-releasing hormone agonist therapy. Int J Fertil Womens Med 1999;44:260–4.
   PubMedGoogle Scholar
• Chwalisz K, Perez MC, Demanno D, et al. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005;26:423e38.
   Web of Science ®Google Scholar
• Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 2013;34:130e62.
   Web of Science ®Google Scholar
• Mehasseb MK, Panchal R, Taylor AH, et al. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil Steril 2011;95:2228–35.
   PubMed Web of Science ®Google Scholar
• Mori T, Ito F, Matsushima H, et al. Dienogest reduces HSD17β1 expression and activity in endometriosis. J Endocrinol 2015;225:69–76.
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Kimura F, Kishi Y, et al. Progesterone and synthetic progestin, Dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells. Eur J Obstet Gynecol Reprod Biol 2014;179:170–4.
   PubMed Web of Science ®Google Scholar
• Maia H, Jr, Maltez A, Coelho G, et al. Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003;10:512–16.
   PubMedGoogle Scholar
• Li L, Leng JH, Zhang JJ, et al. Changes of menstruation patterns and adverse effects during the treatment of LNG-IUS for symptomatic adenomyosis. Zhonghua Fu Chan Ke Za Zhi 2016;51:657–62.
   Google Scholar
• Park DS, Kim ML, Song T, et al. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol 2015;54:412–15.
   PubMed Web of Science ®Google Scholar
• Pervez SN, Javed K. Adenomyosis among samples from hysterectomy due to abnormal uterine bleeding. J Ayub Med Coll Abbottabad 2013;25:68–70.
   PubMedGoogle Scholar
• Finco A, Centini G, Lazzeri L, Zupi E. Surgical management of abnormal uterine bleeding in fertile age women. Womens Health (Lond) 2015;11:513–25.
   PubMedGoogle Scholar
• Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril 2014;101:472–87.
   PubMed Web of Science ®Google Scholar
• Kang L, Gong J, Cheng Z, et al. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion. J Minim Invasive Gynecol 2009;16:169–73.
   PubMed Web of Science ®Google Scholar
• Wang CJ, Yen CF, Lee CL, Soong YK. Laparoscopic uterine artery ligation for treatment of symptomatic adenomyosis. J Am Assoc Gynecol Laparosc 2002;9:293–6.
   PubMedGoogle Scholar
• Takeuchi H, Kitade M, Kikuchi I, et al. Laparoscopic adenomyomectomy and hysteroplasty: a novel method. J Minim Invasive Gynecol 2006;13:150–4.
   PubMed Web of Science ®Google Scholar
• Tsui KH, Lee WL, Chen CY, et al. Medical treatment for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol 2014;53:459–65.
   PubMed Web of Science ®Google Scholar
• Osada H, Silber S, Kakinuma T, et al. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Bio Med Online 2011;22:94–9.
   PubMed Web of Science ®Google Scholar
• Makarenko TA, Tskhay VB. The experience of organ-preserving surgical treatment of patients with severe forms of adenomyosis. J Оbstetr Gynecol Dis (Rus) 2016;65:96–9.
   Google Scholar
• Tskhay VB, Tsygankovа NY. Modern methods of surgical treatment of severe adenomyosis. Siber Med Rev (Rus) 2016;98:22–31.
   Google Scholar
• Issa JP. Cancer prevention: epigenetics steps up to the plate. Cancer Prev Res (Phila) 2008;1:219–22.
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148–59.
   PubMed Web of Science ®Google Scholar
• Deng Y, Yu B, Cheng Q, et al. Epigenetic silencing of WIF-1 in hepatocellular carcinomas. J Cancer Res Clin Oncol 2010;136:1161–7.
   PubMed Web of Science ®Google Scholar
• Di Domenico M, Santoro A, Ricciardi C, et al. Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. Cancer Biol Ther 2011;12:447–57.
   PubMed Web of Science ®Google Scholar